Kahortagga isbaarada difaaca waa nooc dawooyin ah oo la dagaallama nidaamka difaaca jirka si ay ula dagaallamaan unugyada kansarka. Si kastaba ha ahaatee, bukaanada intooda badani kama jawaabaan daawayntan. Waxaa jira daroogo cusub oo bartilmaameedsanaysa laba borotiin oo ku lug leh xakamaynta jawaabta difaaca jirka ee ka hortagga burooyinka.
Phase I of clinical trials has shown some exciting results, which were conducted in 19 patients suffering from kansarka with the molecule M7824. These researchers are also undertaking trials with those suffering from kansarka ganaca and those infected with HPV.
There are many other trials and experiments being taken to treat and daawo kansarka more effectively in different research institutes. This drug with a dual approach will be a boon in the daaweynta kansarka, as with a single molecule, multiple therapies are included.
